Drugs Made In America Acquisition Corp. Units (DMAAU) — Tangible Net Worth Ratio
Drugs Made In America Acquisition Corp. Units (DMAAU) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($232.64 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Drugs Made In America Acquisition Corp. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Drugs Made In America Acquisition Corp. Units Tangible Net Worth Ratio (2025–2025)
This chart shows how Drugs Made In America Acquisition Corp. Units's Tangible Net Worth Ratio has changed across 1 annual periods from 2025 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $232.64 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see Drugs Made In America Acquisition Corp. (DMAAU) total market value.
Annual Tangible Net Worth Ratio for Drugs Made In America Acquisition Corp. Units (2025–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Drugs Made In America Acquisition Corp. Units from 2025 to 2025, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Drugs Made In America Acquisition Corp. (DMAAU) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $232.64 Million | $0.00 | $239.92 Million | — |